Gene Therapy for Mucopolysaccharidosis Market

List of Tables and Figures

Figure 1. Total Sales by Application of Gene Therapy for Mucopolysaccharidosis Industry (Volume)
Figure 2. Gene Therapy for Mucopolysaccharidosis Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Gene Therapy for Mucopolysaccharidosis Revenue in 2022
Figure 5. US Gene Therapy for Mucopolysaccharidosis Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Gene Therapy for Mucopolysaccharidosis Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Gene Therapy for Mucopolysaccharidosis Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Gene Therapy for Mucopolysaccharidosis Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Gene Therapy for Mucopolysaccharidosis Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Gene Therapy for Mucopolysaccharidosis Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Gene Therapy for Mucopolysaccharidosis Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Gene Therapy for Mucopolysaccharidosis Revenue, by Type (Million USD) (2018-2028)
Table 4. Gene Therapy for Mucopolysaccharidosis Sales, by Type (K Unit) (2018-2028)
Table 5. Gene Therapy for Mucopolysaccharidosis Sales (K Unit) by Application (2018-2028)
Table 6. Gene Therapy for Mucopolysaccharidosis Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Gene Therapy for Mucopolysaccharidosis Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Gene Therapy for Mucopolysaccharidosis Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Gene Therapy for Mucopolysaccharidosis Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Gene Therapy for Mucopolysaccharidosis Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Gene Therapy for Mucopolysaccharidosis Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Gene Therapy for Mucopolysaccharidosis Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Gene Therapy for Mucopolysaccharidosis Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Gene Therapy for Mucopolysaccharidosis Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Gene Therapy for Mucopolysaccharidosis in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Gene Therapy for Mucopolysaccharidosis in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Gene Therapy for Mucopolysaccharidosis in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Gene Therapy for Mucopolysaccharidosis in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Gene Therapy for Mucopolysaccharidosis in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Gene Therapy for Mucopolysaccharidosis in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Gene Therapy for Mucopolysaccharidosis in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Sangamo Therapeutics Profiles
Table 61. Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Product Introduction
Table 62. Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Sangamo Therapeutics Strategic initiatives
Table 64. Swedish Orphan Biovitrum Profiles
Table 65. Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Product Introduction
Table 66. Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Swedish Orphan Biovitrum Strategic initiatives
Table 68. uniQure Profiles
Table 69. uniQure Gene Therapy for Mucopolysaccharidosis Product Introduction
Table 70. uniQure Gene Therapy for Mucopolysaccharidosis Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. uniQure Strategic initiatives